Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Filings indexed 3,334 across all filing types
Latest filing 2020-11-10 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Tezepelumab Phase III trial met primary endpoint
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and the date format typical of regulatory news service announcements. The content details positive results from a Phase III clinical trial (NAVIGATOR) for a drug (tezepelumab) and mentions that the results will be presented at a forthcoming medical meeting. This is an announcement of scientific/clinical data, not the full financial report (10-K), a quarterly report (IR), or a formal earnings release (ER) which focuses on financial metrics. Since it is a specific announcement of clinical trial data and partnership updates released via the RNS system, it fits best under the general 'Regulatory Filings' (RNS) category, as there is no specific category for 'Clinical Trial Results Announcement'. Given the context of a major drug trial update released via RNS, RNS is the most appropriate general regulatory filing code.
2020-11-10 English
CALQUENCE APPROVED IN THE EU FOR CLL
Foreign Filer Report
2020-11-09 English
Calquence approved in the EU for CLL
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 6388E' and is dated '09 November 2020'. It announces a regulatory approval ('Calquence approved in the EU') and provides detailed clinical trial results and company commentary. The presence of the RNS header and the nature of the announcement (a significant corporate/product update distributed via a regulatory news service) strongly suggests this is a general regulatory announcement. Since it is not a full Annual Report (10-K), a specific financial statement (IR/MRQ), a transcript (CT), or a proxy statement (DEF 14A), and it is a formal announcement distributed via RNS, the most appropriate classification is Regulatory Filings (RNS). The document length is substantial (12,636 chars), suggesting it is the full announcement, not just a brief notice of publication (RPA).
2020-11-09 English
BRILINTA APPROVED IN THE US IN STROKE
Foreign Filer Report
2020-11-06 English
Brilinta approved in the US in stroke
Regulatory Filings Classification · 98% confidence The document is clearly identified as originating from 'RNS Number : 4958E' and includes the standard footer information stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content is a press release announcing a regulatory event: the US FDA approval of Brilinta for a new indication. This type of immediate, material corporate announcement distributed via an official news service like RNS, which doesn't fit neatly into specific financial report categories (like 10-K, ER, or IR), is best classified as a general Regulatory Filing or announcement. Since 'RNS' is explicitly defined as the fallback for miscellaneous regulatory announcements, it is the most appropriate code.
2020-11-06 English
AZN: YEAR-TO-DATE AND Q3 2020 RESULTS
Foreign Filer Report
2020-11-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.